CDK4/6 inhibitor
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for CDK4/6 inhibitor, covering 2022-08-02 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) [Phase 3]